Lamictal (lamotrigine) monotherapy for typical absence seizures in children

Epilepsia

Volumn 40, Issue 7, 1999, Pages 973-979

  Frank, L Matthew ^a   Enlow, Thomas ^b   Holmes, Gregory L ^c   Manasco, Penelope ^d   Concannon, Susan ^d   Chen, Chao ^d   Womble, Gilda ^d   Casale, Eugene J ^d  

^a CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^b AKRON CHILDREN'S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Absence seizures; Efficacy; Lamotrigine; Pediatric; Tolerability

Indexed keywords

LAMOTRIGINE; PLACEBO;

ABSENCE; ARTICLE; ASTHENIA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPERKINESIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0033051765     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00805.x     Document Type: Article

References (23)

1. Sandstedt P. Primary generalized epilepsies in childhood. In: Sillanpaa M, Johannessen S, Blenow G, Dam M, eds. Paediatric epilepsy. Petersfield, UK: Wrightson Biomedical Publishing, 1990: 99-109.
2. Holmes G, McKeever M, Adamson M. Absence seizures in children: clinical and electroencephalographic features. Ann Neurol 1987;21:268-73.
3. Holmes G, Casale EJ, Manasco P. Seizure frequency and duration in untreated, newly diagnosed children and adolescents with typical absence seizures. Neurology 1997;48:43A.
4. Miller A, Wheatley PL, Sawyer D, Baxter M, Roth B. Pharmacological studies on lamotrigine, a novel antiepileptic drug: I. Anti-convulsant profile in mice and rats. Epilepsia 1986;27:483-9.
5. Peck AW. Clinical pharmacology of lamotrigine. Epilepsia 1991; 32(suppl):S9-12.
6. Peck AW. Lamotrigine: historical background. Rev Contemp Pharmacother 1994;5:95-105.
7. Leach M, Marden C, Miller A. Pharmacological studies on lamotrigine, a novel antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia 1986;27:490-7.
8. Lees G, Leach MJ. Studies on the mechanism of action of the novel anti-convulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res 1993;612:190-9.
9. Risner M. Multi-center, double-blind, placebo-controlled, add-on crossover study of lamotrigine (Lamictal) in epileptic outpatients with partial seizures. Epilepsia 1990;31:619.
10. Richens A, Yuen AWC. Overview of the clinical efficacy of lamotrigine. Epilepsia 1991;32(suppl):S13-6.
11. Amery W, Dony J. A clinical trial design avoiding undue placebo treatment. J Clin Pharmacol 1975;13:674-9.
12. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1989;30:389-99.
13. Besag FMC. Lamotrigine in the management of subtle seizures. Rev Contemp Pharmacother 1994;5:123-31.
14. Schlumberger E, Chavez F, Palacios L, et al. Lamotrigine in the treatment of 120 children with epilepsy. Epilepsia 1994;35:359-67.
15. Strumia S, Hirsch E, Moszowski J, Marescaux C. Lamotrigine effect in typical absences. Epilepsia 1994;35(suppl 8):118.
16. Buchanan N. Lamotrigine in the treatment of absence seizures. Acta Neurol Scand 1995;92:348-57.
17. Lapovilla G, Gatti A, Veggiotti PA. Lamotrigine monotherapy in the treatment of absence seizures in children. Epilepsia 1997;38: 96-104.
18. Goa KL, Ross SR, Chrisp P. Lamotrigine: a review of its clinical pharmacological properties and clinical efficacy in epilepsy. Drugs 1993;46:152-76.
19. Sato S. Generalized seizures: absence. In: Dreifuss FE, ed. Pediatric epileptology: classification and management of seizures in the child. John Wright, 1983:65-91.
20. Crews RD, Sidell AD. The clinical significance of spike and wave abnormalities in the adult. Bull Los Angeles Neurol Soc 1973;38: 60-8.
21. Callaghan N, O'Hare J, O'Driscoll D, O'Neill B, Daly M. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (petit mal). Dev Med Child Neurol 1982;24:830-6.
22. ™ (lamotrigine) monotherapy for the treatment of newly-diagnosed typical absence seizures in children and adolescents. Epilepsia 1996;37:A165.
23. Frank LM, Casale E, Womble G, Manasco P. Lamictal is effective for the treatment of typical absence seizures in children and adolescents. Ann Neurol 1997;42:489A.